# Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 withdrawing the approval of the active substance Z,Z,Z,Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance) (revoked)

EU Regulation 2016/636 · adopted 22 April 2016

Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 withdrawing the approval of the active substance Z,Z,Z,Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

## Introductory text

Commission Implementing Regulation (EU) 2016/636
of 22 April 2016
withdrawing the approval of the active substance Z,Z,Z,Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance) (revoked)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 1 Withdrawal of approval

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 2 Amendment to Implementing Regulation (EU) No 540/2011

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 3 Transitional measures

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 4 Grace period

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 5 Entry into force

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Signature

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eur/2016/636 (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-636
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

